Thursday, November 6, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Rush Street Interactive Registered (A) Stock: Record Quarter Sparks Growth

Dieter Jaworski by Dieter Jaworski
July 31, 2025
in Stocks
0
Rush Street Interactive Registered (A) Stock
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Rush Street Interactive exceeded all expectations in its recent second-quarter earnings report, driving the stock up 2.75% to $15.95 in after-hours trading. The gaming company reported earnings of $0.11 per share, significantly outperforming analyst estimates of $0.06 – an impressive 83% beat. Revenue reached $269 million, surpassing forecasts by nearly 8% and marking a 22% year-over-year increase. The adjusted EBITDA skyrocketed to $40.2 million, representing an 88% jump from the previous year and establishing a new company record. Management has substantially raised its 2025 guidance, now projecting revenue between $1.05 billion and $1.1 billion (16% growth) and adjusted EBITDA between $133 million and $147 million (51% increase).

Regional Performance Highlights

Latin America emerged as a powerful growth engine with monthly active users increasing by over 40% despite challenging year-over-year comparisons. Mexico stood out with revenue surging more than 125% year-over-year and 40% quarter-over-quarter. North American markets also delivered strong results, with Michigan growing 42%, West Virginia 47%, and Ontario 25% – its best performance since 2023. The company achieved these results while reducing marketing expenses to just 13.5% of revenue, the lowest percentage since its IPO. With $241 million in cash and zero debt, Rush Street Interactive maintains a solid financial foundation to support continued expansion.

Ad

Rush Street Interactive Registered (A) Stock: Buy or Sell?! New Rush Street Interactive Registered (A) Analysis from November 6 delivers the answer:

The latest Rush Street Interactive Registered (A) figures speak for themselves: Urgent action needed for Rush Street Interactive Registered (A) investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 6.

Rush Street Interactive Registered (A): Buy or sell? Read more here...

Tags: Rush Street Interactive Registered (A)
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Royal Gold Stock
Stocks

Royal Gold Shares Surge to Record High on Acquisition Momentum

September 29, 2025
Unitedhealth Stock
Stocks

UnitedHealth Shares Present Conflicting Outlook for Investors

September 29, 2025
ASML Stock
Stocks

ASML Forges Strategic AI Alliance to Bolster Semiconductor Dominance

September 29, 2025
Next Post
Nurix Therapeutics Inc Stock

Nurix Therapeutics Inc Stock: Executives Sell Amid Analyst Disagreement

Axos Stock

Axos Stock: Q4 Earnings Exceed Expectations

Aurora Innovation Stock

Aurora Innovation Stock: Driverless Trucks Roll While Cash Burns

Recommended

Uranium Energy Stock

Goldman Sachs Bolsters Uranium Energy with Major Share Purchase

4 weeks ago
aTyr Pharma Stock

Clinical Trial Failure Sends aTyr Pharma Shares into Freefall

1 month ago
Procter & Gamble Stock

Procter & Gamble Shares Slide to Annual Low Despite Dividend Increase and Strong Shareholder Support

3 weeks ago
PepsiCo Stock

Behind PepsiCo’s Strong Earnings: A Concerning Volume Trend

4 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

DuPont Faces Critical Test as Quarterly Results Loom

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

Emerson Electric’s Strategic Pivot Faces Market Scrutiny

EU Grant Provides Critical Boost for LanzaTech’s Carbon Recycling Technology

Is Darden Restaurants Facing a Critical Test?

Critical Juncture for USA Rare Earth as Earnings and Chinese Export Curbs Collide

Trending

Analysis

BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise

by Andreas Sommer
November 6, 2025
0

BioNTech presents investors with a complex financial picture marked by contradictory signals. The German biotech firm reported...

Illumina Stock

China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally

November 6, 2025
Iovance Stock

Iovance Faces Critical Test as Q3 Earnings Approach

November 6, 2025
DuPont de Nemours Stock

DuPont Faces Critical Test as Quarterly Results Loom

November 6, 2025
Sarepta Therapeutics Stock

Sarepta Therapeutics Shares Plummet Following Critical Clinical Trial Failure

November 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • BioNTech’s Crossroads: Navigating Losses Amid Cancer Research Promise
  • China Lifts Export Ban on Illumina’s DNA Sequencers, Sparking Market Rally
  • Iovance Faces Critical Test as Q3 Earnings Approach

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com